Your browser doesn't support javascript.
loading
Significance of validated symptom assessment versus breath testing for malabsorption after lactose load in children.
Sterniste, Georg; Hammer, Karin; Memaran, Nima; Huber, Wolf-Dietrich; Hammer, Johann.
Afiliação
  • Sterniste G; Abteilung für Gastroenterologie und Hepatologie, Universitätsklinik für Innere Medizin 3.
  • Hammer K; St. Anna Kinderspital, Medical University of Vienna, Vienna, Austria.
  • Memaran N; Department of Pediatric Kidney, Liver and Metabolic Diseases, Hannover Medical School, Hannover, Germany.
  • Huber WD; Klinische Abteilung für Pädiatrische Nephrologie und Gastroenterologie, Universitätsklinik für Kinder- und Jugendheilkunde, Medical University of Vienna, Vienna, Austria.
  • Hammer J; Abteilung für Gastroenterologie und Hepatologie, Universitätsklinik für Innere Medizin 3.
Eur J Gastroenterol Hepatol ; 34(3): 274-280, 2022 03 01.
Article em En | MEDLINE | ID: mdl-35100175
BACKGROUND AND OBJECTIVES: Lactose malabsorption and lactose-induced symptoms are poorly correlated, as shown by breath tests and various symptom assessment methods. Validated assessment is the key to overcome the limitations of biased symptom measurements. We characterized lactose-induced symptoms with the population-specific, validated paediatric carbohydrate perception questionnaire (pCPQ) and their correlation with the history of symptoms (HoS). METHODS: A total of 130 patients with functional gastrointestinal symptoms underwent a lactose hydrogen breath and tolerance test (LBTT) allowing for a diagnosis of malabsorption (M+) and lactose sensitivity (S+). HoS indicative of lactose-induced symptoms (abdominal pain, nausea, bloating, flatulence, diarrhoea) in the 4 weeks preceding the test was determined using a validated questionnaire. The pCPQ was used to score lactose-induced symptoms. MAIN RESULTS: The LBTT revealed 41 children (31.5%) with lactose malabsorption (M+), 56 (43.1%) with lactose sensitivity (S+) and 24 (18.5%) were M+/S+. Sensitivity correlated with HoS (P < 0.001), regardless of whether malabsorption was detectable. Malabsorption status did not correlate with HoS (NS). The odds of lactose sensitivity significantly increased when abdominal pain [odds ratio (OR) 3.5, confidence interval (CI) 1.6-7.8], nausea (OR 2.3, CI, 1.1-4.9) and flatulence (OR 3.1, CI 1.4-6.8) were reported in the 4 weeks preceding the LBTT. Symptoms after the lactose load were similar for M+/S+ and M-/S+, except for flatulence, which was more frequent in malabsorbers (P < 0.01). CONCLUSION: Our findings fit well with the emerging view of the important role of a validated symptom assessment after a lactose load. The determination of symptoms may be more relevant than malabsorption for the clinical outcomes of paediatric patients with lactose-related gastrointestinal symptoms.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Gastroenteropatias / Intolerância à Lactose Tipo de estudo: Diagnostic_studies / Etiology_studies Limite: Child / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Gastroenteropatias / Intolerância à Lactose Tipo de estudo: Diagnostic_studies / Etiology_studies Limite: Child / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article